NOTV - Inotiv, Inc. Stock Price, Fair Value and News

1.93USD-0.21 (-9.81%)Delayed

Market Summary

USD1.93-0.21

Delayed

-9.81%

NOTV Stock Price

View Fullscreen

NOTV RSI Chart

NOTV Valuation

Market Cap

50.1M

Price/Earnings (Trailing)

-0.7

Price/Sales (Trailing)

0.09

EV/EBITDA

0.96

Price/Free Cashflow

1.53

NOTV Price/Sales (Trailing)

NOTV Profitability

EBT Margin

-15.02%

Return on Equity

-34.41%

Return on Assets

-8.74%

Free Cashflow Yield

65.5%

NOTV Fundamentals

NOTV Revenue

Revenue (TTM)

552.7M

Rev. Growth (Yr)

-21.41%

Rev. Growth (Qtr)

-12.15%

NOTV Earnings

Earnings (TTM)

-71.3M

Earnings Growth (Yr)

-381.08%

Earnings Growth (Qtr)

-212.44%

Breaking Down NOTV Revenue

Last 7 days

-48.7%

Last 30 days

-64.4%

Last 90 days

-67.7%

Trailing 12 Months

-70.1%

How does NOTV drawdown profile look like?

NOTV Financial Health

Current Ratio

0.37

Debt/Equity

Debt/Cashflow

119.38

NOTV Investor Care

Shares Dilution (1Y)

0.82%

Diluted EPS (TTM)

-2.77

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	552.7M	0	0	0
2023	597.3M	582.2M	572.4M	585.2M
2022	277.5M	427.3M	547.7M	586.2M
2021	68.2M	75.3M	89.6M	155.9M
2020	54.6M	59.5M	60.5M	65.4M
2019	33.0M	36.5M	43.6M	49.1M
2018	23.0M	23.2M	26.3M	29.6M
2017	22.7M	23.5M	24.2M	23.4M
2016	21.4M	20.3M	20.4M	21.7M
2015	24.0M	24.1M	22.7M	21.7M
2014	23.2M	23.7M	24.6M	24.2M
2013	24.7M	23.1M	22.1M	22.5M
2012	31.1M	29.8M	28.2M	26.5M
2011	31.0M	32.1M	33.1M	32.6M
2010	0	0	28.8M	29.9M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Inotiv, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Dec 14, 2023	beattie john gregory	bought	149,836	3.1238	47,966	chief operating officer
Dec 14, 2023	garrett michael	bought	14,145	2.829	5,000	chief commercial officer
Oct 17, 2023	coelho mary theresa	acquired	-	-	12,911	-
Apr 01, 2023	neff r matthew	acquired	-	-	25,822	-
Apr 01, 2023	landman david	acquired	-	-	25,822	-
Apr 01, 2023	brown nigel	acquired	-	-	25,822	-
Apr 01, 2023	davis gregory cole	acquired	-	-	25,822	-
Apr 01, 2023	johnson richard allen	acquired	-	-	25,822	-
Mar 30, 2023	beraldi fernanda	acquired	-	-	2,500	former gen'l counsel & sec'y
Mar 14, 2023	sagartz john e	bought	25,041	4.91	5,100	chief strategy officer

Which funds bought or sold NOTV recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	unchanged	-	29,080	43,760	-%
May 16, 2024	JANE STREET GROUP, LLC	added	168	818,687	935,665	-%
May 15, 2024	D. E. Shaw & Co., Inc.	new	-	1,620,340	1,620,340	-%
May 15, 2024	CITADEL ADVISORS LLC	added	211	823,715	923,227	-%
May 15, 2024	Brevan Howard Capital Management LP	new	-	232,934	232,934	-%
May 15, 2024	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	unchanged	-	2,472	3,720	-%
May 15, 2024	TWO SIGMA INVESTMENTS, LP	added	298	2,183,890	2,384,480	0.01%
May 15, 2024	WYNNEFIELD CAPITAL INC	reduced	-46.5	327,489	877,989	0.35%
May 15, 2024	GOLDMAN SACHS GROUP INC	added	546	2,320,670	2,447,610	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	added	91.3	4,364,600	5,292,730	-%

Are Funds Buying or Selling NOTV?

Are funds buying NOTV calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NOTV

No. of Funds

Unveiling Inotiv, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 03, 2024	jermyn street associates llc	4.89%	1,260,024	SC 13D/A
Feb 14, 2023	iszo capital lp	0%	0	SC 13G/A
Oct 06, 2022	jermyn street associates llc	5.4%	1,378,280	SC 13D/A
Sep 20, 2022	p2 capital partners, llc	2.8%	715,705	SC 13D/A
Jul 05, 2022	jermyn street associates llc	8.1%	2,077,422	SC 13D/A
Feb 14, 2022	iszo capital lp	5.3%	1,275,379	SC 13G/A
Feb 11, 2022	portolan capital management, llc	3.00%	728,395	SC 13G/A
Feb 10, 2022	renaissance technologies llc	2.12%	516,565	SC 13G/A

Recent SEC filings of Inotiv, Inc.

View All Filings

Date Filed	Form Type	Document
May 16, 2024	10-Q/A	Quarterly Report
May 15, 2024	8-K	Current Report
May 15, 2024	10-Q	Quarterly Report
May 13, 2024	NT 10-Q	NT 10-Q
Apr 03, 2024	SC 13D/A	13D - Major Acquisition
Mar 21, 2024	3	Insider Trading
Mar 19, 2024	8-K	Current Report

Peers (Alternatives to Inotiv, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	196.9B	23.7B	11.04%	17.40%	44.73	8.29	-8.94%	-35.91%
A	45.2B	6.7B	14.64%	19.44%	36.57	6.71	-2.81%	-6.58%
IDXX	44.9B	3.7B	13.71%	10.52%	51.83	12.06	8.57%	23.94%
DGX	16.0B	9.3B	13.66%	10.24%	18.95	1.73	-3.29%	6.68%
NTRA	13.1B	1.2B	17.80%	114.36%	-35.76	10.81	39.26%	33.08%
MEDP	12.2B	2.0B	2.71%	87.82%	38.94	6.2	25.57%	21.62%
CRL	11.4B	4.1B	-3.66%	11.24%	26.02	2.78	0.49%	-11.59%
EXAS	9.3B	2.5B	-20.33%	-38.03%	-38.69	3.67	15.21%	53.51%
MID-CAP
GH	3.1B	603.7M	54.73%	-14.09%	-6.73	5.14	25.21%	30.68%
NEOG	2.9B	929.2M	11.70%	-18.80%	1.9K	3.16	28.93%	111.61%
SMALL-CAP
CDNA	808.3M	275.1M	87.44%	103.94%	-4.41	2.94	-13.93%	-126.97%
ACRS	84.8M	31.1M	-3.25%	-85.34%	-1.1	2.73	0.95%	19.75%
AWH	33.0M	9.2M	-24.07%	-37.65%	-2.24	3.6	11.85%	45.80%
APDN	2.5M	5.5M	-62.31%	120.18%	-0.2	0.45	-68.52%	-141.15%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Inotiv, Inc. News

Latest updates

Inotiv, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q2
Revenue	-12.2%	119,035	135,501	140,740	157,468	151,463	122,754	150,466	172,666	140,313	84,211	30,077	22,892	18,751	17,885	15,774	15,765	16,012	12,918	14,786	10,861	10,103
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	10,331	7,646	6,280	5,877	4,447	5,064	5,193	3,477	5,926	3,129	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	13,739	9,349	6,801	5,863	5,818	5,541	5,388	4,497	5,421	3,379	-
S&GA Expenses	1.0%	5,403	5,348	5,036	4,793	4,758	4,501	4,463	4,802	4,647	2,738	1,174	838	880	625	527	692	1,447	882	876	730	-
R&D Expenses	-	-	-	-	-	-	-	-	-	-	-	7.00	107	203	196	188	105	162	162	230	128	-
EBITDA Margin	-67.0%	0.03*	0.10*	-0.05*	-0.47*	-0.46*	-0.46*	-0.50*	-0.08*	-0.20*	-0.46*	0.16*	0.03*	-	-	-	-	-	-	-	-	-
Interest Expenses	-2.4%	11,088	11,364	11,268	10,786	10,515	10,450	8,888	8,441	7,547	4,828	521	449	366	347	405	382	392	311	216	178	-
Income Taxes	-82.1%	-6,364	-3,494	1,480	-2,380	-2,466	-15,974	-9,590	342	6,846	-12,785	-	-4,753	15.00	33.00	18.00	21.00	11.00	97.00	2.00	-	-
Earnings Before Taxes	-181.8%	-54,443	-19,322	-7,226	-2,015	-12,095	-102,906	-253,221	-3,214	182	-96,196	9,312	-2,151	-708	-333	-1,774	-858	-577	-1,329	292	-426	-
EBT Margin	-116.1%	-0.15*	-0.07*	-0.22*	-0.64*	-0.62*	-0.61*	-0.64*	-0.21*	-0.32*	-0.58*	0.07*	-0.07*	-	-	-	-	-	-	-	-	-
Net Income	-212.4%	-48,079	-15,388	-9,663	1,840	-9,994	-87,323	-244,156	-3,728	-6,087	-83,047	9,382	2,602	-723	-366	-1,792	-879	-588	-1,426	290	-426	-
Net Income Margin	-127.3%	-0.13*	-0.06*	-0.18*	-0.58*	-0.58*	-0.58*	-0.62*	0.03*	0.04*	0.07*	0.12*	0.00*	-	-	-	-	-	-	-	-	-
Free Cashflow	358.5%	16,918	-6,545	18,763	3,694	12,836	-7,410	171	-9,415	5,170	-1,143	2,697	3,523	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-2.4%	815	836	857	855	869	871	963	1,168	1,139	1,004	322	177	65.00	63.00	62.00	64.00	62.00	61.00	42.00	39.00	32.00
Current Assets	-5.2%	181	191	214	203	211	213	233	235	226	174	189	48.00	18.00	16.00	15.00	17.00	16.00	15.00	12.00	11.00	8.00
Cash Equivalents	48.6%	33.00	22.00	35.00	22.00	25.00	21.00	19.00	21.00	47.00	42.00	139	-	2.00	1.00	1.00	3.00	0.00	1.00	1.00	1.00	1.00
Inventory	-10.3%	45.00	51.00	56.00	54.00	64.00	76.00	71.00	66.00	57.00	36.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Net PPE	-0.1%	191	192	191	189	188	188	186	187	153	133	48.00	45.00	29.00	29.00	29.00	29.00	28.00	27.00	23.00	21.00	18.00
Goodwill	0%	94.00	94.00	94.00	94.00	94.00	91.00	158	6.00	457	1.00	52.00	51.00	4.00	4.00	4.00	4.00	4.00	7.00	4.00	4.00	3.00
Liabilities	4.6%	608	581	588	580	596	591	603	554	522	413	217	83.00	57.00	55.00	54.00	54.00	52.00	51.00	31.00	28.00	21.00
Current Liabilities	350.2%	493	109	132	121	132	136	164	146	132	107	55.00	47.00	36.00	35.00	32.00	29.00	29.00	28.00	17.00	16.00	12.00
Long Term Debt	-99.9%	0.00	371	370	372	370	366	331	334	332	255	154	29.00	18.00	17.00	19.00	21.00	19.00	19.00	14.00	12.00	9.00
LT Debt, Current	4422.1%	380	8.00	8.00	4.00	4.00	8.00	8.00	5.00	5.00	5.00	10.00	15.00	8.00	7.00	6.00	4.00	2.00	1.00	1.00	1.00	1.00
LT Debt, Non Current	-100.0%	-	371	370	372	370	366	331	334	332	255	154	29.00	18.00	17.00	19.00	21.00	19.00	19.00	14.00	12.00	9.00
Shareholder's Equity	-18.5%	207	254	269	276	273	280	360	614	617	590	105	94.00	7.00	7.00	8.00	9.00	10.00	10.00	11.00	10.00	10.00
Retained Earnings	-10.2%	-517	-469	-453	-444	-444	-435	-348	-104	-101	-94.43	-11.01	-20.40	-23.00	-22.28	-21.91	-20.12	-19.24	-18.65	-17.10	-17.39	-16.96
Additional Paid-In Capital	0.3%	717	715	716	714	712	710	708	715	713	679	112	110	27.00	27.00	27.00	27.00	26.00	26.00	25.00	25.00	25.00
Shares Outstanding	0.4%	26.00	26.00	26.00	26.00	26.00	26.00	26.00	26.00	23.00	21.00	16.00	12.00	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-0.66	-0.73	-1.31	-1.00	-0.61	-0.14	-0.24	-0.62	-	-	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	100	-	-	-	483	-	-	-	172	-	-	-	25.00	-	-	-	15.00

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	358.5%	16,918	-6,545	18,763	3,694	12,836	-7,410	171	-9,415	5,170	-1,143	2,697	3,523	2,874	1,652	-296	1,240	-1,106	1,452	210	656	4.00
Share Based Compensation	-0.7%	1,884	1,897	1,988	2,029	1,781	2,046	1,917	1,985	1,141	19,159	746	580	279	181	160	176	123	81.00	82.00	72.00	99.00
Cashflow From Investing	-13.5%	-4,587	-4,043	-7,699	-4,492	-8,406	-8,158	-15,595	-14,506	-71,228	-232,393	-5,006	-46,629	-951	-1,474	-1,037	-1,743	-1,255	-6,096	-2,348	-3,583	-1,534
Cashflow From Financing	59.8%	-1,173	-2,921	-310	-1,042	-1,160	18,384	13,989	-1,369	71,065	119,466	134,573	65,580	-892	-429	-209	3,253	2,048	4,549	2,238	2,913	1,327

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NOTV Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue	$ 119,035	$ 151,463	$ 254,536	$ 274,217
Costs and expenses:
Selling	5,403	4,764	10,751	9,265
General and administrative	19,796	28,293	39,723	56,591
Depreciation and amortization of intangible assets	14,155	12,990	28,405	26,253
Other operating expense	30,440	4,812	33,759	8,451
Goodwill impairment loss	0	0	0	66,367
Operating loss	(43,116)	(2,125)	(52,487)	(92,703)
Other (expense) income:
Interest expense	(11,088)	(10,515)	(22,452)	(20,965)
Other (expense) income	(239)	545	1,174	(1,333)
Loss before income taxes	(54,443)	(12,095)	(73,765)	(115,001)
Income tax benefit	6,364	2,466	9,858	18,440
Consolidated net loss	(48,079)	(9,629)	(63,907)	(96,561)
Less: Net income (loss) attributable to noncontrolling interests	0	365	(440)	756
Net loss attributable to common shareholders	$ (48,079)	$ (9,994)	$ (63,467)	$ (97,317)
Earnings Per Share [Abstract]
Net loss attributable to common shareholders, basic (in dollars per share)	$ (1.86)	$ (0.39)	$ (2.46)	$ (3.79)
Net loss attributable to common shareholders, diluted (in dollar per share)	$ (1.86)	$ (0.39)	$ (2.46)	$ (3.79)
Weighted-average number of common shares outstanding:
Basic (in shares)	25,831	25,687	25,797	25,645
Diluted (in shares)	25,831	25,687	25,797	25,645
Service
Revenue	$ 56,961	$ 58,752	$ 110,824	$ 108,800
Costs and expenses:
Cost of revenue (excluding depreciation and amortization of intangible assets)	38,663	36,803	77,740	70,804
Product
Revenue	62,074	92,711	143,712	165,417
Costs and expenses:
Cost of revenue (excluding depreciation and amortization of intangible assets)	$ 53,694	$ 65,926	$ 116,645	$ 129,189

NOTV Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 32,695	$ 35,492
Trade receivables and contract assets, net of allowances for credit losses of $6,459 and $7,446, respectively	65,757	87,383
Inventories, net	45,406	56,102
Prepaid expenses and other current assets	36,821	33,408
Assets held for sale	0	1,418
Total current assets	180,679	213,803
Property and equipment, net	191,423	191,068
Operating lease right-of-use assets, net	46,796	38,866
Goodwill	94,286	94,286
Other intangible assets, net	291,331	308,428
Other assets	10,863	10,079
Total assets	815,378	856,530
Current liabilities:
Accounts payable	28,381	32,564
Accrued expenses and other current liabilities	31,102	25,776
Fees invoiced in advance	41,675	55,622
Current portion of long-term operating lease	11,413	10,282
Current portion of long-term debt	380,358	7,950
Total current liabilities	492,929	132,194
Long-term operating leases, net	37,218	29,614
Long-term debt, less current portion, net of debt issuance costs	275	369,795
Other long-term liabilities	38,055	6,373
Deferred tax liabilities, net	39,739	50,064
Total liabilities	608,216	588,040
Contingencies (Note 14)
Shareholders’ equity and noncontrolling interest:
Authorized 74,000,000 shares at March 31, 2024 and September 30, 2023; 25,905,395 issued and outstanding at March 31, 2024 and 25,777,169 at September 30, 2023	6,438	6,406
Additional paid-in capital	717,139	715,696
Accumulated deficit	(517,185)	(453,278)
Accumulated other comprehensive income	770	330
Total equity attributable to common shareholders	207,162	269,154
Noncontrolling interest	0	(664)
Total shareholders’ equity and noncontrolling interest	207,162	268,490
Total liabilities and shareholders’ equity and noncontrolling interest	$ 815,378	$ 856,530

About Inotiv, Inc.

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services including, computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes, general and genetic toxicology, regulated bioanalysis, biotherapeutics, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes, nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

CEO	Mr. Robert W. Leasure Jr.
WEBSITE	inotivco.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	2099

Inotiv, Inc. Frequently Asked Questions

What is the ticker symbol for Inotiv, Inc.? What does NOTV stand for in stocks?

NOTV is the stock ticker symbol of Inotiv, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Inotiv, Inc. (NOTV)?

As of Fri May 17 2024, market cap of Inotiv, Inc. is 50.12 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NOTV stock?

You can check NOTV's fair value in chart for subscribers.

What is the fair value of NOTV stock?

You can check NOTV's fair value in chart for subscribers. The fair value of Inotiv, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Inotiv, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NOTV so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Inotiv, Inc. a good stock to buy?

The fair value guage provides a quick view whether NOTV is over valued or under valued. Whether Inotiv, Inc. is cheap or expensive depends on the assumptions which impact Inotiv, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NOTV.

What is Inotiv, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, NOTV's PE ratio (Price to Earnings) is -0.7 and Price to Sales (PS) ratio is 0.09. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NOTV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Inotiv, Inc.'s stock?

In the past 10 years, Inotiv, Inc. has provided -0.032 (multiply by 100 for percentage) rate of return.